Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

The Outcome of Tisagenlecleucel (Tisa-Cel) Vs Axicabtagene Ciloleucel (Axi-Cel) CD-19 CAR-T Cell Therapy in Relapsed/Refractory NHL, Real World Data, Single Institution Experience

Reem Alasbali, Abdulrahman Nasiri, Alfadil Adam, Saud Alhayli, Naeem A. Chaudhri, Alfadel Alshaibani, Abdulwahab Albabtain, Hadeel Samarkandi, Ayman Saad, Abdullah Alamer, Tusneem Ahmed M Elhassan, Hazza A. Alzahrani, Syed Osman Ahmed, Walid Rasheed, Riad Elfakih, Mahmoud Aljurf, ALI D Alahmari

Blood (2023) 142 (Supplement 1): 6936.

https://doi.org/10.1182/blood-2023-182580

Published: 2023

Journal Articles

Excellent Outcomes of HLA Matched Related Donor Transplant for Adults with Severe Sickle Cell Disease Using a Non-Myeloablative Conditioning with Thiotepa and Post-Transplant Cyclophosphamide: Multi-Center International Experience

Reem Alasbali, Mohsen Alzahrani, Saud Alhayli, Walid Rasheed, Phavina Akhom, Karina Wilkerson, Mohammed Essa, Riad Elfakih, Bader Alahmari, Hadeel Samarkandi, Syed Osman Ahmed, Ayman Saad, Hazza A. Alzahrani, Fahad Almohareb, Mahmoud Aljurf, Adetola A. Kassim, Ali D Alahmari

Blood (2023) 142 (Supplement 1): 1042.

https://doi.org/10.1182/blood-2023-189914

Published: 2023

Journal Articles

Superior Outcome of Bone Marrow Transplantation Using Fludarabine and Cyclophosphamide with ATG over Fludarabine and Cyclophosphamide without ATG Conditioning Regimen in Severe Aplastic Anemia

Blood (2023) 142 (Supplement 1): 6951.

https://doi.org/10.1182/blood-2023-182333

Published: 2023

Journal Articles

Allogeneic Stem Cell Transplantation in Adolescent and Adult Patients with Acute T Cell Lymphoblastic Leukemia / Lymphoma : Single Center Experience of 143 Patients

Blood (2023) 142 (Supplement 1): 7101.

https://doi.org/10.1182/blood-2023-185676

Published: 2023

Journal Articles

Blinatumomab with Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

Blood (2023) 142 (Supplement 1): 5889.

https://doi.org/10.1182/blood-2023-180221

Published: 2023

Journal Articles

Molecular Characterisation and Outcomes of 363 Adolescent and Young Adults with AML in Saudi Arabia Risk Stratified By PCR and NGS-Based Testing

Blood (2023) 142 (Supplement 1): 7433.

https://doi.org/10.1182/blood-2023-187940

Published: 2023

Journal Articles

Clinical Characterization, Cancer Incidence and Long-Term Outcomes of Fanconi Anemia Patients : A Single Center Analysis of 97 Patients

Blood (2022) 140 (Supplement 1): 11471–11473.

https://doi.org/10.1182/blood-2022-162734

Published: 2022

Journal Articles

Allogeneic Hematopoietic Cell Transplant Yields Long Term Disease Free Survival in a Significant Number of Patients with Classic Hodgkin Lymphoma

Blood (2022) 140 (Supplement 1): 12969–12970.

https://doi.org/10.1182/blood-2022-164820

Published: 2022

Journal Articles

Utility and Validity of Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) in Predicting Overall Survival and Non-Relapse Mortality in Adolescent and Young Adult Population

Blood (2022) 140 (Supplement 1): 10566–10567.

https://doi.org/10.1182/blood-2022-167509

Published: 2022

Journal Articles

Successful Restoration of Nivolumab Efficacy Post Allogeneic Stem Cell Transplantation in Hodgkin's Lymphoma

Khawlah Farhan, Abdulwahab Albabtain, Saud Alhayli, Walid Rasheed, Alfadel Alshaibani, Naeem A. Chaudhri, Ali Alahmari, Mahmoud Aljurf, Riad El Fakih

Blood (2022) 140 (Supplement 1): 12048–12049.

https://doi.org/10.1182/blood-2022-158953

Published: 2022

Journal Articles

Sequential Fludarabine, Ara-C, Etoposide (FLAV) Followed By Fludarabine/ Busulfan Reduced Toxicity Conditioning Is Safe and Effective Salvage for Adult Patients with Refractory Acute Myeloid Leukemia and High Risk Myelodysplasia

Blood (2021) 138 (Supplement 1): 1851.

https://doi.org/10.1182/blood-2021-152602

Published: 2021

Journal Articles

Proteomics Analysis Reveals Protein Panels That Are Associated with Prediction to Tyrosine Kinase Inhibitors Response, Bone Marrow Transplant, Survival and Disease Outcome of Chronic Myeloid Leukemia Patients

Ayodele Alaiya, MPH, MBBS, PhD, Mahmoud Aljurf, MD, Zakia Shinwari, MSc, Fahad Z. Alsharif, MB, MD, Hazza A. Alzahrani, MD, Syed Osman Ahmed, BSc, FRCPath, MBBS, MRCP, Tarek Owaidah, MD FRCPA, Amr Suleiman Hanbali, MD, Marwan Shaheen, MD, Feras Al Fraih, MD, Riad Elfakih, MD, Saud Alhayli, MD, Shahrukh Hashmi, MD, Walid Rasheed, MB, ChB, FRACP, FRCPA, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD

Blood (2018) 132 (Supplement 1): 5434.

https://doi.org/10.1182/blood-2018-99-118754

Published: 2018

Journal Articles

A Clinical, Genomic and Proteomic Approach for the Characterization of Fanconi Anemia in Adolescent and Young Adult (AYA) Patients : A Single Center Study of 55 Patients from a National Bone Marrow Failure Referral Center

Blood (2018) 132 (Supplement 1): 2594.

https://doi.org/10.1182/blood-2018-99-114639

Published: 2018

Journal Articles

The Impact of Early Post-Transplant Cyclosporine Induced Acute Nephrotoxicity on Long Term Renal Function in 2-Year Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Retrospective Study

Reem Alharbi, Mahmoud Aljurf, MD, Raid El Fakih, MD, Mohammad Al Nahedh, PharmD, Majed Huessein, MD, Zubeir Ahmed Nurgat, BSc, MSc, Almohareb Fahad, MD, Naeem A. Chaudhri, MD, Fahad Z. Alsharif, MB, MD, Hazza A. Alzahrani, MD, Walid Rasheed, MB, ChB, FRACP, FRCPA, Amr Suleiman Hanbali, MD, Marwan Shaheen, MD, Feras Al Fraih, MD, Saud Alhayli, MD, Riad Youniss, Shahrukh Hashmi, MD, Syed Osman Ahmed, BSc, FRCPath, MBBS, MRCP

Blood (2018) 132 (Supplement 1): 3358.

https://doi.org/10.1182/blood-2018-99-114667

Published: 2018

Journal Articles

Refined Hepatic Grading System Improves Risk Stratification of Long-Term Outcomes in the Patients Developing Chronic Gvhd

Saud Alhayli, MBBS, Elizabeth Shin, Wilson Lam, MD, Uday Deotare, MD DM, Fotios V. Michelis, MD PhD, Santhosh Thyagu, MBBS, MD DM, Auro Viswabandya, MD DM, Jeffrey H. Lipton, Hans A. Messner, PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2016) 128 (22): 2235.

https://doi.org/10.1182/blood.V128.22.2235.2235

Published: 2016

NARROW

The Outcome of Tisagenlecleucel (Tisa-Cel) Vs Axicabtagene Ciloleucel (Axi-Cel) CD-19 CAR-T Cell Therapy in Relapsed/Refractory NHL, Real World Data, Single Institution Experience

Excellent Outcomes of HLA Matched Related Donor Transplant for Adults with Severe Sickle Cell Disease Using a Non-Myeloablative Conditioning with Thiotepa and Post-Transplant Cyclophosphamide: Multi-Center International Experience

Superior Outcome of Bone Marrow Transplantation Using Fludarabine and Cyclophosphamide with ATG over Fludarabine and Cyclophosphamide without ATG Conditioning Regimen in Severe Aplastic Anemia

Allogeneic Stem Cell Transplantation in Adolescent and Adult Patients with Acute T Cell Lymphoblastic Leukemia / Lymphoma : Single Center Experience of 143 Patients

Blinatumomab with Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

Molecular Characterisation and Outcomes of 363 Adolescent and Young Adults with AML in Saudi Arabia Risk Stratified By PCR and NGS-Based Testing

Clinical Characterization, Cancer Incidence and Long-Term Outcomes of Fanconi Anemia Patients : A Single Center Analysis of 97 Patients

Allogeneic Hematopoietic Cell Transplant Yields Long Term Disease Free Survival in a Significant Number of Patients with Classic Hodgkin Lymphoma

Utility and Validity of Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) in Predicting Overall Survival and Non-Relapse Mortality in Adolescent and Young Adult Population

Successful Restoration of Nivolumab Efficacy Post Allogeneic Stem Cell Transplantation in Hodgkin's Lymphoma

Sequential Fludarabine, Ara-C, Etoposide (FLAV) Followed By Fludarabine/ Busulfan Reduced Toxicity Conditioning Is Safe and Effective Salvage for Adult Patients with Refractory Acute Myeloid Leukemia and High Risk Myelodysplasia

Proteomics Analysis Reveals Protein Panels That Are Associated with Prediction to Tyrosine Kinase Inhibitors Response, Bone Marrow Transplant, Survival and Disease Outcome of Chronic Myeloid Leukemia Patients

A Clinical, Genomic and Proteomic Approach for the Characterization of Fanconi Anemia in Adolescent and Young Adult (AYA) Patients : A Single Center Study of 55 Patients from a National Bone Marrow Failure Referral Center

The Impact of Early Post-Transplant Cyclosporine Induced Acute Nephrotoxicity on Long Term Renal Function in 2-Year Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Retrospective Study

Refined Hepatic Grading System Improves Risk Stratification of Long-Term Outcomes in the Patients Developing Chronic Gvhd

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only